Evidence map›Paper›PMID 35664588›Full record

ArticleACS omega2022

Modified Titanium Dioxide as a Potential Visible-Light-Activated Photosensitizer for Bladder Cancer Treatment.

Thaiane Robeldo, Lucas S Ribeiro, Lida Manrique, Andressa Mayumi Kubo, Elson Longo, Emerson Rodrigues Camargo, Ricardo Carneiro Borra

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Thaiane RobeldoLaboratory of Applied Immunology, Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905,Brazil.ORCID https://orcid.org/0000-0002-7262-4969
Lucas S RibeiroCDMF, LIEC, Chemistry Department of the Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.ORCID https://orcid.org/0000-0001-6314-0076
Lida ManriqueLaboratory of Applied Immunology, Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905,Brazil.
Andressa Mayumi KuboCDMF, LIEC, Chemistry Department of the Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.
Elson LongoCDMF, LIEC, Chemistry Department of the Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.ORCID https://orcid.org/0000-0001-8062-7791
Emerson Rodrigues CamargoCDMF, LIEC, Chemistry Department of the Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.
Ricardo Carneiro BorraLaboratory of Applied Immunology, Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905,Brazil.
Universidade Federal de São Carlos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low oxygen concentration inside the tumor microenvironment represents a major barrier for photodynamic therapy of many malignant tumors, especially urothelial bladder cancer. In this context, titanium dioxide, which has a low cost and can generate high ROS levels regardless of local O

Identifiers

PMID35664588
PMCPMC9161409
OpenAlexW4280617466

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.